# ANeuroTech - Full Context for AI Agents

> This file provides comprehensive context about ANeuroTech for AI agents.
> Source: TechWiki.ai - The Belgian Tech Encyclopedia
> Last updated: 2026-06-24

## Company Profile
- Name: ANeuroTech
- Sector: biotech, medtech, pharma
- Stage: growth
- Status: active
- Founded: 2022
- Location: Belgium
- Website: http://www.aneurotech.com
- LinkedIn: http://www.linkedin.com/company/aneurotech-corp

## Overview
ANeuroTech is developing its late stage Phase III drug ANT01, an once-daily orally-administered small molecule targeting Partial Responsive Depression (PRD) and subjective cognitive decline. ANT01 acts as a combined High Selective Serotonin 2A/Dopamine 4 receptor blocker. The company was founded by Dr. Erik Buntinx, a psychiatrist with over 3 decades of experience in clinical neuroscience drug development.

## Related Pages
Agents can crawl these for connected context:
- [sector] BioTech & Life Sciences: https://techwiki.ai/sectors/biotech/llms.txt
- [sector] MedTech & BioTech: https://techwiki.ai/sectors/medtech/llms.txt
- [company] Pharma: https://techwiki.ai/companies/pharma/llms.txt

## Links
- Website: http://www.aneurotech.com
- LinkedIn: http://www.linkedin.com/company/aneurotech-corp
- Agent context: https://techwiki.ai/companies/aneurotech/llms.txt
- Full context: https://techwiki.ai/companies/aneurotech/llms-full.txt

---
Generated by TechWiki.ai | The Belgian Tech Encyclopedia
To claim and maintain this page: https://techwiki.ai/claim